Conditions in blood sampling procedures that extend the ex vivo stability of eosinophil activity markers in peripheral blood from allergic patients and healthy controls
- 30 November 1999
- journal article
- Published by Elsevier in Annals of Allergy, Asthma & Immunology
- Vol. 83 (5) , 413-421
- https://doi.org/10.1016/s1081-1206(10)62839-6
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Blood Sample Processing Effect on Eosinophil Cationic Protein ConcentrationAnnals of Allergy, Asthma & Immunology, 1997
- The degree of natural allergen exposure modifies eosinophil activity markers in the circulation of patients with mild asthmaAllergy, 1996
- Eosinophil density: what does it mean? what does it mean?Clinical and Experimental Allergy, 1995
- Eosinophils and asthma. What do measurements tell us?Clinical and Experimental Allergy, 1995
- Peripheral eosinophil counts as a marker of disease activity in intrinsic and extrinsic asthmaClinical and Experimental Allergy, 1995
- Prominent neutrophilic inflammation in sputum from subjects with asthma exacerbationJournal of Allergy and Clinical Immunology, 1995
- Intracellular and surface distribution of CD9 in human eosinophilsAPMIS, 1995
- Effect of clotting temperature and eosinophil concentration on the eosinophil cationic protein concentration in serumScandinavian Journal of Clinical and Laboratory Investigation, 1994
- Counts of activated blood eosinophils for monitoring asthmaAllergy, 1993
- Expression of complement receptors type 1 (CR1) and type 3 (CR3) on circulating granulocytes in experimentally provoked asthmaJournal of Allergy and Clinical Immunology, 1989